OIRA Conclusion of EO 12866 Regulatory Review
| RIN: 0938-AU37 View EO 12866 Meetings | Received Date: 04/30/2021 |
| Title: CY 2022 Home Health Prospective Payment System Rate Update, Home Infusion Therapy Services, and Quality Reporting Requirements (CMS-1747) | |
| Agency/Subagency: HHS / CMS | Stage: Proposed Rule |
| Concluded Action: Consistent with Change | Concluded Date: 06/24/2021 |
| Legal Deadline: Statutory | Economically Significant: Yes |
| Publication Date: | Unfunded Mandates: No |
| Major: Yes | Related To Homeland Security: No |
| Regulatory Flexibility Analysis Required: Undetermined | Small Entities Affected: |
| Federalism Implications: No | Affordable Care Act [Pub. L. 111-148 & 111-152]: No |
| International Impacts: No | Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No |
| Pandemic Response: No | |
An official website of the United States government



